Oxymatrine Downregulates TLR4, TLR2, MyD88, and NF-κB and Protects Rat Brains against Focal Ischemia by Fan, Hongguang et al.
Hindawi Publishing Corporation
Mediators of Inﬂammation
Volume 2009, Article ID 704706, 10 pages
doi:10.1155/2009/704706
Research Article
OxymatrineDownregulatesTLR4, TLR2, MyD88, andNF-κBa n d
Protects Rat Brainsagainst FocalIschemia
HongguangFan,LitaoLi,XiangjianZhang,YingLiu,ChenhuiYang,YiYang,andJing Yin
Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China
Correspondence should be addressed to Xiangjian Zhang, zhang6xj@heinfo.net
Received 27 May 2009; Revised 16 August 2009; Accepted 17 November 2009
Recommended by Philipp Lepper
Inﬂammatorydamageplaysanimportantroleincerebral ischemicpathogenesisandmayrepresentatargetfortreatment.Toll-like
receptor-4 (TLR4), toll-like receptor-2 (TLR2), myeloid diﬀerentiation factor 88 (MyD88), and nuclear factor kappa-B (NF-κB)
have been linked to inﬂammatory reactions. Our previous studies have proved that oxymatrine (OMT) protected ischemic brain
injury and this eﬀect may be through the decreasing of NF-κB expression. However, little is known regarding the mechanism
of OMT in the acute phase of ischemic stroke. We therefore investigated the OMT’s potential neuroprotective role and the
underlying mechanisms. Male, Sprague-Dawley rats were randomly divided into sham, saline and OMT treatment groups. We
used a middle cerebral artery occlusion (MCAO) model and administered OMT intraperitoneally immediately after cerebral
ischemia and once daily on the following days. At time points after MCAO, brain water content and infarct size were measured.
Immunohistochemistry and RT-PCR were used to analyse the expression of TLR4, TLR2, MyD88, and NF-κB at gene and protein
level in ischemic brain tissue. The result indicated that OMT protected the brain from damage caused by MCAO; this eﬀect may
be through downregulation of the TLR4, TLR2, MyD88, and NF-κB.
Copyright © 2009 Hongguang Fan et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
The excessive inﬂammatory immune reaction often resides
in region of necrosis and ischemic tissue after cerebral
infarctionandleadstoinﬂammatoryinjury.Therelationship
between toll-like receptor-4 (TLR4), toll-like receptor-2
(TLR2), and nonbiological inﬂammatory injury has been
proved [1–3]. It is believed that injured tissue and necrotic
cells release endogenous activators (adjuvants). These acti-
vators can combine with TLR4 in the cell membrane. With
the assistance of cluster of diﬀerentiation-14 (CD14) and
myeloid diﬀerentia protein 2 (MD2), they activate nuclear
factor kappa-B (NF-κB) and release a series of cytokines
to counteract inﬂammation. Potential ligands also activate
TLR2. They can also induce speciﬁc immunity to increase
the self-protection ability of the organism. An excessive
inﬂammatory reaction can also damage target cells and
tissue [4, 5]. Reducing the inﬂammatory injury is therefore
regarded to be one of major ways to treat acute cerebral
infarction.
The pathway mediated by TLR4 includes myeloid dif-
ferentiation protein-88- (MyD88-) dependent and MyD88-
independentpathways[6].ThroughTLR4intrinsicactivator,
the former can combine with CD14 and anchor on cell
surface. Through the eﬀect of MD2, the combination of
intrinsic activator and TLR4 can induce a series of intracel-
lular signal transductions. NF-κB is activated to cause release
of inﬂammatory factors. The MyD88-independent pathway
belongs to the TLR4-TRIF (TIR-domain-containing adaptor
protein inducing IFNβ)p a t h w a y[ 7, 8] and also has a close
relationship with TLR4. The pathway induced by TLR2 is
restricted to MyD88-dependent pathways.
Oxymatrine (OMT) has a tetracyclic quinolizine struc-
ture. Its molecular formula is C15H24N2O. The structure
of OMT is shown in Figure 1.I ti sa na l k a l o i de x t r a c t e d
from Sophora ﬂavescens Ait (a traditional Chinese medicine
(TCM) belonging to the pulse family). The antiinﬂamma-
tory, antioxidative and antivirus eﬀects of OMT, as well as
its role in immunological regulation, have been reported
[9, 10]. In recent years, OMT studies have focused mainly2 Mediators of Inﬂammation
Table 1: Summary of the RT-PCR Primers sequences.
Gene Primers Sequences
TLR4 Forward 5 -GCC GGA AAG TTA TTG TGG TGG T-3 
Reverse 5 -ATG GGT TTT AGG CGC AGA GTT T- 3 
TLR2 Forward 5 -GAA AGA TGC GCT TCC TGA AC-3 
Reverse 5 -CGC CTA AGA GCA GGA TCA AC-3 
MyD88 Forward 5 -CAA CCA GCA GAA ACA GGA GTC T-3 
Reverse 5 -ATT GGG GCA GTA GCA GAT GAA G-3 
NF-κBF o r w a r d5  -GCG CAT CCA GAC CAA CAA TAA C-3 
Reverse 5 -GCC GAA GCT GCA TGG ACA CT- 3 
β-actin Forward 5 -GCC ATG TAC GTA GCC ATC CA-3 
Reverse 5 -GAA CCG CTC ATT GCC GAT AG -3 
N
N
O
O
H
H
H
H
Figure 1: The chemical structure of OMT.
on its therapeutic eﬀect against hepatitis and certain types of
t u m o r .Th e r eh a v ebee nf e wr e po rt so nt h ei n ﬂ u e n c eo fO M T
on cerebrovascular disease.
2.MaterialsandMethods
OMT was purchased from Shanxi Huike Botanical Develop-
ment Company Limited (Shanxi, China). It had a purity of
98%. The ﬁne powder of OMT was prepared as a suspension
(40mg/mL) with distilled water and stored at 4◦C.
Animal resource and model building. Male Sprague-
Dawley (SD) rats (240–260g) were provided by the Exper-
imental Animal Center, Preclinical Medical College, Hebei
Medical University (Hebei, China). They were housed in
multilayer laminar ﬂow racks. They could move about freely
and had a standard diet and puriﬁed water. The room
temperature was maintained at 20–25◦C. According to the
methods reported by Longa [11] and Laing et al. [12], an
animal model of middle cerebral artery occlusion (MCAO)
was established by the suture embolic method.
2.1. Experimental Design. To observe the inﬂuence of OMT
on infarction size, water content, and inﬁltration of inﬂam-
matorycellsgeneexpressionandproteinexpressionofTLR4,
TLR2, MyD88, and NF-κB in ischemic brain tissue, rats were
divided into three groups, that is, OMT treatment group
(120mg/kg), saline group, and sham operation group. Each
group was divided into three subgroups at diﬀerent time
points (6 hours, 24 hours, and 48 hours after operation).
OMT suspension (40mg/mL) was given to rats in the OMT
treatment group via intraperitoneal injection (120mg/kg)
after MCAO, then once a day. Rats in the saline group
received1mLofsalinereplacingOMTafterMCAOusingthe
same method.
2.2. Detection of Water Content in Brain Tissue. The water
content of brain tissue was detected using the dry-wet
weight technique. Five rats of each group were killed,
brain tissues were harvested quickly, and the frontal pole
(thickness, 4mm) removed. Brain tissue behind the frontal
pole (thickness, 2mm) was selected for detection of water
content. After ascertaining the wet weight (WW) with
an electronic balance, brain tissue was put into an oven
at constant temperature (100 ± 5◦C) for 24 hours. The
dry weight (DW) was then obtained. Water content was
calculatedbasedontheformula:(WW−DW)/WW ×100%.
2.3. Determination of Infarction Size. 2, 3, 5-triphenyl-
tetrazolium (TTC) stain of brain tissue was used. Three
rats of each group were killed, brain tissues were harvested
quickly, and the frontal pole and cerebella removed. Coronal
slices of thickness 2mm were prepared. Brain tissue was
divided into ﬁve portions, immersed in 2% TTC phosphonic
buﬀer, and incubated at 37
◦C for 30minutes. Viable brain
tissue was stained red by TTC, whereas necrotic brain tissue
was pale white. Slices were preserved in 10% formaldehyde.
The apical side of each slice was imaged. The area of
infarction on both sides of each slice was determined by an
image analyzer.
2.4. Detection of Expression of TLR4, TLR2, MyD88, and
NF-κB in Brain Tissue by Immunohistochemistry. Sections
were deparaﬃnized by a standard method. They were then
incubated in 3% H2O2/methanol to eliminate endogenous
peroxidase activity. After rinsed with phosphate-buﬀered
saline (PBS; 0.01M, pH 7.4) for antigen retrieval, sections
were placed in citrate buﬀer (0.01mol/L, pH 6.0) for 30
minutes. Sections were cooled at room temperature and
incubated with normal goat serum. Sections were incubated
successively with primary antibody (for TLR4 and NF-κB,
1:400,SantaCruzBiotechnology;forTLR2,1:400,LifeSpan
Bioscience; for MyD88, 1:100, Santa Cruz Biotechnology)
overnight at 4◦C. They were rinsed with PBS and incubated
with biotinylation secondary antibody ﬂuid at 37
◦Cf o r4 5
minutes. They were rinsed again with PBS and incubatedMediators of Inﬂammation 3
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Figure 2: Relative infarct volume and water content in the brain. (a) and (b) TTC stain: comparison of infarct size between the saline group
and OMT treatment group at 24 hours. The white region was the infarction and the red region was normal brain tissue. (c) Relative infarct
volume: calculating and comparing the percentage of infarct region occupying the whole brain tissue area in one section revealed that it
decreased by 32% in the OMT treatment group compared with the saline group at 24 hours. ∗P<. 05 compared with saline group. (d) Water
content of cerebral tissue: there was no diﬀerence at 6 hours among the test groups. It increased at 24 hours in the saline group and lasted
up to 48 hours in the saline group at identical time points. Water content in the OMT treatment group decreased at 24 hours and 48 hours
after the operation compared with that in the saline group at the same time points. Results are means ± SD of each group. ∗∗P<. 01 and
∗P<. 05 compared with Sham.
with horseradish peroxidase-labeled streptoavidin at 37
◦C.
Slices were developed with diaminobenzidene (DAB) and
counterstained with hematoxylin. They were dehydrated and
mounted. The expression of TLR4, TLR2, MyD88, and NF-
κBinbraintissuewascalculated.Threesectionsofeachbrain
were selected every 100μm interval. Six scopes were selected
randomly in the infarcted cortex and immunopositive cells
were counted. The average number was calculated and
represented the immunopositive cells of that rat, and three
rats were used in each group.
2.5. Reverse Transcription-Polymerase Chain Reaction (RT-
PCR). Ischemic brain tissue was harvested quickly. Total
RNA was extracted with Trizol (Invitrogen) and the density
and purity detected. RNA (2μg) of each sample was used
for synthesizing cDNA through inverse transcription; 1μL
of cDNA was used to carry out PCR ampliﬁcation. Primers
were synthesized by Shanghai Sangon Biological Engineering
TechnologyCompanyLimited.Correctnessofthegeneorder
w a sp r o v e di nG e n B a n k( Table 1). PCR conditions were
initial denaturation for 2 minutes at 95
◦C, 35 cycles of
ampliﬁcation with denaturation at 95
◦C for 30 seconds,
annealing at 52
◦C for 30 seconds, and extension at 72
◦C
for 40 seconds. After 35 cycles, extension at 72
◦Cf o r5
minutes was done. RT-PCR products (5μL) were analyzed
by 2% agarose gel electrophoresis. The gray scale of the
electrophoresis strip was scanned by an ultraviolet photom-
etry (UVP) gel imaging system. The relative expression of
products was represented with TLR4/β-actin, TLR2/β-actin,
MyD88/β-actin, and NF-κB/β-actin; data were analyzed with
an image analysis system.
2.6. Data Analysis. Data were analyzed using software SAS
6.8. Results were means ± SD. Single-factor variance analysis4 Mediators of Inﬂammation
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Figure 3: RT-PCR results of TLR4 and NF-κB. (a) RT-PCR of TLR4 at 24 hours after the operation in each group: expression of TLR4
mRNA was evidently higher in the saline group compared with the OMT treatment group, and the diﬀerence was signiﬁcant (P<. 05). (b)
RT-PCR of NF-κB 24 hours after the operation in each group: expression of NF-κB mRNA was similar to that of TLR4 mRNA. (c) RT-PCR
of TLR4 at all time points: expression of TLR4 mRNA showed no diﬀerence among all test groups at 6 hours. It was evidently higher in the
saline group at 12 hours and lasted up to 48 hours. Compared with the saline group at identical time points, expression of TLR4 mRNA was
lower in the OMT treatment group, and the diﬀerence was signiﬁcant ∗∗P<. 01 and ∗P<. 05 compared with Sham. (d) RT-PCR of NF-κB
at all time points: expression of NF-κBm R N Aw a ss i m i l a rt ot h a to fT L R 4m R N A∗∗P<. 01 and ∗P<. 05 compared with Sham.
was used to compare the diﬀerence between groups, and the
q test was used to compare diﬀerences between two groups.
P<. 05 was considered signiﬁcant.
3. Results
3.1. OMT Reduced the Infarction Size of Ischemic Brain Tissue.
The infarction size in ischemic brain tissue was reduced by
32% in the OMT treatment group compared with that in the
salinegroup24hoursafteroperation(Figures 2(a),2(b),and
2(c)).
3.2. OMT Reduced the Water Content of Brain Tissue. With
respect to cerebral water content, the following results were
noted. There was no diﬀerence at 6 hours among the test
groups. No change was found at all time points in the sham
group. Cerebral water content increased at 24 hours in the
saline group and lasted up to 48 hours in the saline group.
It was evidently lower in the OMT treatment group, and the
diﬀerence was signiﬁcant (Figure 2(d)).
3.3.OMTReducedtheExpressionofTLR4,TLR2,MyD88,and
NF-κBm R N A . The expression of TLR4, TLR2, MyD88, and
NF-κB mRNA in the brain tissue of each group was detected
by RT-PCR 24 hours after the operation. The level of TLR4
mRNA expression was higher in the saline group than that
in the sham operation group, and was lower in the OMT
treatment group than in the saline group. The diﬀerences
had statistical signiﬁcance (Figure 3(a)). Expression of NF-
κB mRNA 24 hours after the operation was higher in the
saline group than in the sham group and was lower in
the OMT treatment group than in the saline group. The
diﬀerences had statistical signiﬁcance (Figure 3(b)). Results
a r ee x p r e s s e da sm e a n s± SD of each group (∗∗P<. 01 and
∗P<. 05 compared with Sham (Figures 3(c) and 3(d))).
The level of TLR2 mRNA expression was higher in the
saline group than that in the sham operation group and was
lower in the OMT treatment group than in the saline group.
The diﬀerences had statistical signiﬁcance (Figure 4(a)).
Expression of MyD88 mRNA 48 hours after the operation
was higher in the saline group than in the sham group and
was lower in the OMT treatment group than in the salineMediators of Inﬂammation 5
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Figure4:RT-PCRresultsofTLR2andMyD88.(a)RT-PCRofTLR2at24hoursaftertheoperationineachgroup:expressionofTLR2mRNA
was evidently higher in the saline group compared with that in the OMT treatment group, and the diﬀerence was signiﬁcant (P<. 05). (b)
RT-PCR of MyD88 at 48 hours after the operation in each group: expression of MyD88 mRNA was similar to that of TLR2 mRNA. (c)
RT-PCR of TLR2 at all time points: expression of TLR2 mRNA was evidently higher in the saline group at 6 hours and lasted up to 48 hours.
There was no diﬀerence between saline and OMT group at 6 hours. Compared with the saline group at 24 hours and 48 hours, expression
of TLR2 mRNA was lower in the OMT treatment group, and the diﬀerence was signiﬁcant ∗∗P<. 05 compared with Sham and ∗P<. 05
compared with saline group. (d) RT-PCR of MyD88 at all time points: expression of mRNA was similar to that of TLR2 mRNA. ∗∗P<. 05
compared with Sham and ∗P<. 05 compared with saline group.
group. The diﬀerences had statistical signiﬁcance (Figure 4
part (b)). Results are expressed as means ± SD of each group
(∗∗P<. 05 compared with Sham and ∗P<. 05 compared
with saline group (Figures 4(c) and 4(d))).
3.4.OMTReducedtheExpressionofTLR4,TLR2,MyD88,and
NF-κBProtein. ExpressionofTLR4proteinincerebraltissue
was detected by an immunohistochemical technique at 24
hours after the operation in each group. TLR4 expression in
the sham group is shown in Figure 5(a). A high level of TLR4
expression in the saline group was noted (Figure 5(b)). TLR4
expression was lower in the OMT treatment group than in
the saline group; the diﬀerence had statistical signiﬁcance.
Positive cells were deﬁned as having buﬀy grains in the
cytoplasm(Figure 5(c)).Resultsareexpressedasmeans ±SD
of each group (∗∗P<. 01 and ∗P<. 05 compared with Sham
(Figure 5(d))).
Expression ofNF-κBprotein24hoursaftertheoperation
in each group was noted using an immunohistochemical
technique. NF-κB expression in the sham group is shown in
Figure 6(a). A high level of NF-κB expression in the saline
group was observed (Figure 6(b)). NF-κB expression was
lower in the OMT group than in the saline group, and
the diﬀerence had statistical signiﬁcance. Positive cells were
deﬁned as having buﬀy grains in the nucleus and cytoplasm
(Figure 6(c)). Results are expressed as means ± SD of each
group (∗∗P<. 01 and ∗P<. 05 compared with Sham
(Figure 6(d))).
Expression of TLR2 protein 24 hours after the operation
in each group was noted using an immunohistochemical
technique. TLR2 expression in the sham group is shown
in Figure 7(a). A high level of TLR2 expression in the
saline group was observed (Figure 7(b)). TLR2 expression
was lower in the OMT group than in the saline group,
and the diﬀerence had statistical signiﬁcance. Positive cells
were deﬁned as having buﬀy grains in the cytoplasm
(Figure 7(c)). Results are expressed as means ± SD of each6 Mediators of Inﬂammation
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Figure 5: TLR4 expression detected by immunohistochemistry. (a) TLR4 expression in the sham group: TLR4 expression could not be
observed in the sham group at 24 hours. (b) TLR4 expression in the saline group: TLR4 expression evidently increased in the saline group
at 24 hours. Positive cells were deﬁned as having buﬀy grains in the cytoplasm. (c) TLR4 expression in the OMT treatment group: TLR4
expression decreased relatively in the OMT treatment group at 24 hours. (d) TLR4 expression in each group at all time points: TLR4
expression showed no diﬀerence among all the test groups at 6 hours. It was evidently higher in the saline group at 24 hours and lasted up
to 48 hours. Compared with the saline group at identical time points, TLR4 expression was lower in the OMT treatment group, and the
diﬀerence was signiﬁcant ∗∗P<. 01 and ∗P<. 05 compared with Sham.
group (∗∗P<. 05 compared with Sham and ∗P<. 05
compared with saline group (Figure 7(d))).
Expression of MyD88 protein 24 hours after the opera-
tionineachgroupwasnotedusinganimmunohistochemical
technique. MyD88 expression in the sham group is shown
in Figure 8(a). A high level of MyD88 expression in the
saline group was observed (Figure 8(b)). MyD88 expression
was lower in the OMT group than in the saline group, and
the diﬀerence had statistical signiﬁcance. Positive cells were
deﬁnedashavingbuﬀygrainsinthecytoplasm(Figure 8(c)).
Results are expressed as means ± SD of each group (∗∗P<
.05 compared with Sham and ∗P<. 05 compared with saline
group (Figure 8(d))).
4. Discussion
The antiinﬂammatory and antioxidative eﬀects of OMT (as
well as its roles in immunological regulation) have attracted
attention over the past few years [13, 14]. It has been
conﬁrmed that OMT can act on nonspeciﬁc inﬂammatory
reactions [15]. OMT exerts its antiinﬂammatory eﬀect
without dependence of the pituitary-adrenal system: it acts
directly on inﬂammatory cells [15]. OMT is a two-way
immunoregulant. That is, it can stimulate the proliferation
of lymphocytes at low concentrations, and yet inhibit this
proliferation at high concentrations.
Cerebral infarction can be observed in multiple patho-
logical processes [16]a n dc a nb ea ﬀected by multiple
factors. In general, it is believed that cerebral infarction is
a typical noninfective lesion, and that its pathophysiological
mechanism involves the production of oxygen free radicals
and release of inﬂammatory mediators. TLRs are thought
to have important eﬀects on nonbiological inﬂammatory
lesions [1, 17].
TLRs are type-I transmembrane receptors. Their extra-
cellular domain is a pathogen-associated molecular patternMediators of Inﬂammation 7
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Figure 6: NF-κB expression detected by immunohistochemistry. (a) NF-κB expression in the sham group: NF-κB expression could be
observed periodically in the sham group at 24 hours. (b) NF-κB expression in the saline group: NF-κB expression evidently increased in the
saline group at 24 hours. Positive cells were deﬁned as haning buﬀy grains in the cellular nucleus and cytoplasm. (c) NF-κB expression in the
OMT treatment group: NF-κB expression decreased relatively in the OMT treatment group at 24 hours. (d) NF-κB expression in each group
at all time points: there was no diﬀerence among all test groups at 6 hours. It was evidently higher in the saline group at 24 hours and lasted
up to 48 hours. Compared with the saline group at identical time points, NF-κB expression was lower in the OMT treatment group, and the
diﬀerence was signiﬁcant ∗∗P<. 01 and ∗P<. 05 compared with Sham.
(PAMP). Their intracellular part is a structural domain
named Toll/IL-1R (TIR), which can conduct stimulating
signals.Atleast11TLRs(TLR1–TLR11)havebeenidentiﬁed.
TLR4 and TLR2 have been conﬁrmed to participate in the
inﬂammatory reaction, and to promote the maturation and
diﬀerentiation of immune cells. Various TLRs are expressed
in human and murine brains [18, 19]. TLR4 is extensively
expressed in the periventricular plexus, microglial cells and
astrocytes. TLR4 mRNA is also observed in intracerebral
vascular smooth muscle cells and epithelia. TLR2 has been
described to express in astrocytes, microglia, endothelial
cells, ependymal cells, as well as neurons. Many PAMPs can
activate TLR4, including peptidoglycan (PGN), Lipoteichoic
acid (LTA), lipoprotein, and oxidative stress (i.e., oxygen
free radicals). Potential ligands for TLR2 activation are
some endogenous “danger molecules” like high mobility
group box protein 1 (Hmgb1) or heat shock protein 70
(HSP70) [20, 21]. Activated TLR4 and TLR2 then transfer
signals to NF-κB through MyD88-dependent and indepen-
dent pathways and induce activation of proinﬂammatory
cytokines such as tumor necrosis factor-alpha (TNF-α)a n d
interleukins (ILs). TLR family members recognize not only
exogenous microorganisms but also endogenous harmful
substances [22]. For example, they are involved in the
responses to necrotized cells, heat-shock protein, and the
degradation products of the extracellular matrix. It was
recently indicated that TLR4 and TLR2 have critical eﬀects
in injuries to the central nervous system [23–25] and that
the microglial cell is the main mediator of such injuries. As
an inﬂammatory transmembrane receptor, the role of TLRs
has become a controversial issue in the ﬁeld of infective
diseases. There are many studies on the eﬀects of TLR4 in
nonbiological inﬂammatory injuries (e.g., ischemia of the
myocardium, liver, and brain), but there are few reports
on ischemic nonbiological infective injury. After cerebral
infarction, it has been conﬁrmed that the infective injury8 Mediators of Inﬂammation
(a) (b)
(c)
0
5
10
15
20
25
30
35
40
6h 24h 48h
Time points after operation
Sham
Saline
OMT
T
L
R
2
c
e
l
l
s
∗∗
∗∗
∗ ∗ ∗∗
(d)
Figure 7: TLR2 expression detected by immunohistochemistry. (a) TLR2 expression in the sham group: TLR2 expression could be observed
periodically in the sham group at 24 hours. (b) TLR2 expression in the saline group: TLR2 expression evidently increased in the saline group
at 24 hours. Positive cells were deﬁned as presenting buﬀy grains in cytoplasm. (c) TLR2 expression in the OMT treatment group: TLR2
expression decreased relatively in the OMT treatment group at 24 hours. (d) TLR2 expression in each group at all time points: expression of
TLR2 protein was evidently higher in the saline group at 6 hours and lasted up to 48 hours. There was no diﬀerence between saline and OMT
group at 6 hours. Compared with the saline group at 24 hours and 48 hours, expression of TLR2 protein was lower in the OMT treatment
group, and the diﬀerence was signiﬁcant ∗∗P<. 05 compared with Sham and ∗P<. 05 compared with saline group.
around ischemic tissue becomes the direct cause of cerebral
edema [1] but does infective injury after cerebral infarction
correlate to TLR4 and TLR2 levels?
We calculated the water content of brain tissue and the
infarction size (as determined by TTC stain) to evaluate the
inﬂuence of OMT on the expression of TLR4, TLR2, MyD88
and NF-κB in focal cerebral infarction in rats. Expression of
TLR4, TLR2, MyD88, and NF-κBm R N Aa n dp r o t e i ni nt e s t
groupswasdetectedbyRT-PCRandimmunohistochemistry,
respectively. OMT could reduce water content and reduce
the infarction area of ischemic brain tissue. It could also
weaken the expression of TLR4, TLR2, MyD88, and NF-κB
mRNA and protein. We hypothesized that after endogenous
activators were identiﬁed by TLR4 or TLR2, the signal trans-
duction pathway was switched on. This led to recruitment
of MyD88, activation of NF-κB and the subsequent release
of proinﬂammatory cytokines, resulting in tissue injury.
By decreasing the expression of TLR4 and TLR2 gene and
protein, OMT can reduce the expression of MyD88 and
NF-κB gene and protein. This can inhibit inﬂammatory
injury, weaken cerebral edema, and provide neuroprotection
against subsequent cerebral ischemic injury. How TLR4,
TLR2, and a serial of following inﬂammatory factors (such
as MyD88 and NF-κB) regulate the immune system require
further research. Our study showed that administration
of 120mg/kg OMT was suﬃcient to provide signiﬁcant
neuroprotection against neurological injury induced by
MCAO. We supported this ﬁnding by both histological and
neurological data: a reduction in the brain infarct volume.
These results showed that OMT had beneﬁcial eﬀects for
ischemia. However, the potential mechanisms underlying
the neuroprotection of OMT are not yet known. Our study
showedthatOMTmayamelioratetheinﬂammationthrough
reducing the expression of TLR4, TLR2, MyD88, and NF-κB.
In conclusion, our study has conﬁrmed that OMT
protected the brain from damage caused by MCAO; this
eﬀect may be through downregulating the expression of
TLR4, TLR2, MyD88, and NF-κB. The elevated expression
of TLR4, TLR2, MyD88, and NF-κB is thought to be
consistent with ischemia evoked neuron injury and death
through inﬂammatory mechanism. TLR4, TLR2, MyD88,
and NF-κB pathway may be one of the strategic targetsMediators of Inﬂammation 9
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Figure 8: MyD88 expression detected by immunohistochemistry. (a) MyD88 expression in the sham group: MyD88 expression could be
observed periodically in the sham group at 24 hours. (b) MyD88 expression in the saline group: MyD88 expression evidently increased in
the saline group at 24 hours. Positive cells were deﬁned as presenting buﬀy grains in cytoplasm. (c) MyD88 expression in the OMT treatment
group: MyD88 expression decreased relatively in the OMT treatment group at 24 hours. (d) MyD88 expression in each group at all time
points: Expression of MyD88 protein was evidently higher in the saline group at 6 hours and lasted up to 48 hours. There was no diﬀerence
between saline and OMT group at 6 hours. Compared with the saline group at 24 hours and 48 hours, expression of MyD88 protein was
lower in the OMT treatment group, and the diﬀerence was signiﬁcant ∗∗P<. 05 compared with Sham and ∗P<. 05 compared with saline
group.
for cerebral ischemic therapies and OMT maybe a novel,
eﬀectivetherapeuticdrugforthetreatmentofischemicbrain
injury.
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